
Zachariah Lucas
Supervisory Patent Examiner (ID: 15977, Phone: (571)272-0905 , Office: P/1600 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1600, 1648 |
| Total Applications | 707 |
| Issued Applications | 248 |
| Pending Applications | 93 |
| Abandoned Applications | 367 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5760092
[patent_doc_number] => 20060211037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Novel mouse CXC chemokine receptor'
[patent_app_type] => utility
[patent_app_number] => 11/437734
[patent_app_country] => US
[patent_app_date] => 2006-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14064
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211037.pdf
[firstpage_image] =>[orig_patent_app_number] => 11437734
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/437734 | Mouse CXC chemokine receptor | May 21, 2006 | Issued |
Array
(
[id] => 5887724
[patent_doc_number] => 20060275322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Modified HCV peptide vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/429670
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17955
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275322.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429670
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429670 | Modified HCV peptide immunogens | May 4, 2006 | Issued |
Array
(
[id] => 5785277
[patent_doc_number] => 20060205002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins'
[patent_app_type] => utility
[patent_app_number] => 11/429481
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5744
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205002.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429481
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429481 | Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins | May 4, 2006 | Abandoned |
Array
(
[id] => 5148222
[patent_doc_number] => 20070048281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'HCV COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 11/381408
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17946
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048281.pdf
[firstpage_image] =>[orig_patent_app_number] => 11381408
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/381408 | HCV COMBINATION THERAPY | May 2, 2006 | Abandoned |
Array
(
[id] => 5851023
[patent_doc_number] => 20060234214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Methods of detecting hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 11/405032
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7706
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234214.pdf
[firstpage_image] =>[orig_patent_app_number] => 11405032
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/405032 | Methods of detecting hepatitis C virus | Apr 12, 2006 | Abandoned |
Array
(
[id] => 5602348
[patent_doc_number] => 20060292693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Monoclonal antibody with the capability of neutralizing enterovirus type 71 infection'
[patent_app_type] => utility
[patent_app_number] => 11/403070
[patent_app_country] => US
[patent_app_date] => 2006-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5184
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292693.pdf
[firstpage_image] =>[orig_patent_app_number] => 11403070
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/403070 | Monoclonal antibody with the capability of neutralizing enterovirus type 71 infection | Apr 11, 2006 | Issued |
Array
(
[id] => 5034660
[patent_doc_number] => 20070099199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Methods and compositions for treating cervical cancer'
[patent_app_type] => utility
[patent_app_number] => 11/403141
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 54014
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099199.pdf
[firstpage_image] =>[orig_patent_app_number] => 11403141
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/403141 | Methods and compositions for treating cervical cancer | Apr 10, 2006 | Abandoned |
Array
(
[id] => 4778754
[patent_doc_number] => 20080286752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Methods for the production of HCV, assaying HCV entry, and screening drugs and cellular receptors for HCV'
[patent_app_type] => utility
[patent_app_number] => 11/400419
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 32252
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286752.pdf
[firstpage_image] =>[orig_patent_app_number] => 11400419
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/400419 | Methods for the production of HCV, assaying HCV entry, and screening drugs and cellular receptors for HCV | Apr 6, 2006 | Abandoned |
Array
(
[id] => 585386
[patent_doc_number] => 07446177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-04
[patent_title] => 'Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection'
[patent_app_type] => utility
[patent_app_number] => 11/397236
[patent_app_country] => US
[patent_app_date] => 2006-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 33978
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/446/07446177.pdf
[firstpage_image] =>[orig_patent_app_number] => 11397236
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/397236 | Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection | Apr 3, 2006 | Issued |
Array
(
[id] => 5596213
[patent_doc_number] => 20060160130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Recombinant RSV virus expression systems and vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/389618
[patent_app_country] => US
[patent_app_date] => 2006-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20968
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160130.pdf
[firstpage_image] =>[orig_patent_app_number] => 11389618
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/389618 | Recombinant RSV virus expression systems and vaccines | Mar 23, 2006 | Abandoned |
Array
(
[id] => 5204941
[patent_doc_number] => 20070026422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Vaccine-induced hepatitis B viral strain and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/385013
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9315
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20070026422.pdf
[firstpage_image] =>[orig_patent_app_number] => 11385013
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/385013 | Vaccine-induced hepatitis B viral strain and uses thereof | Mar 19, 2006 | Abandoned |
Array
(
[id] => 5051392
[patent_doc_number] => 20070031937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Co-expression of recombinant proteins'
[patent_app_type] => utility
[patent_app_number] => 11/378739
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 9158
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031937.pdf
[firstpage_image] =>[orig_patent_app_number] => 11378739
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/378739 | Co-expression of recombinant proteins | Mar 16, 2006 | Abandoned |
Array
(
[id] => 299725
[patent_doc_number] => 07537924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-26
[patent_title] => 'Virus strains'
[patent_app_type] => utility
[patent_app_number] => 11/372613
[patent_app_country] => US
[patent_app_date] => 2006-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10788
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/537/07537924.pdf
[firstpage_image] =>[orig_patent_app_number] => 11372613
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/372613 | Virus strains | Mar 9, 2006 | Issued |
Array
(
[id] => 5873941
[patent_doc_number] => 20060166193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Binding protein'
[patent_app_type] => utility
[patent_app_number] => 11/372935
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8381
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166193.pdf
[firstpage_image] =>[orig_patent_app_number] => 11372935
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/372935 | Hepatitis C virus E2 binding protein | Mar 8, 2006 | Issued |
Array
(
[id] => 5027998
[patent_doc_number] => 20070269445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV'
[patent_app_type] => utility
[patent_app_number] => 11/369944
[patent_app_country] => US
[patent_app_date] => 2006-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 37610
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269445.pdf
[firstpage_image] =>[orig_patent_app_number] => 11369944
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/369944 | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) | Mar 7, 2006 | Issued |
Array
(
[id] => 5760024
[patent_doc_number] => 20060210969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/366839
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11305
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20060210969.pdf
[firstpage_image] =>[orig_patent_app_number] => 11366839
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/366839 | Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof | Mar 2, 2006 | Issued |
Array
(
[id] => 5520839
[patent_doc_number] => 20090028820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'Antiviral Agent'
[patent_app_type] => utility
[patent_app_number] => 11/885418
[patent_app_country] => US
[patent_app_date] => 2006-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5642
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20090028820.pdf
[firstpage_image] =>[orig_patent_app_number] => 11885418
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885418 | Antiviral Agent | Mar 1, 2006 | Abandoned |
Array
(
[id] => 5785295
[patent_doc_number] => 20060205016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Protein a based binding domains with desirable activities'
[patent_app_type] => utility
[patent_app_number] => 11/357443
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17403
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205016.pdf
[firstpage_image] =>[orig_patent_app_number] => 11357443
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/357443 | Protein a based binding domains with desirable activities | Feb 15, 2006 | Abandoned |
Array
(
[id] => 5748626
[patent_doc_number] => 20060111558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Recombinant infectious laryngotracheitis virus and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/342171
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 24998
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111558.pdf
[firstpage_image] =>[orig_patent_app_number] => 11342171
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/342171 | Recombinant infectious laryngotracheitis virus and uses thereof | Jan 26, 2006 | Issued |
Array
(
[id] => 5912876
[patent_doc_number] => 20060127938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Immunoassay for HIV protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/341550
[patent_app_country] => US
[patent_app_date] => 2006-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5602
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127938.pdf
[firstpage_image] =>[orig_patent_app_number] => 11341550
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/341550 | Immunoassay for HIV protease inhibitors | Jan 25, 2006 | Abandoned |